Kedar Diagnostics And Healthcare Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 13 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.08 Cr
About Kedar Diagnostics And Healthcare
Kedar Diagnostics And Healthcare Private Limited (KDAHPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 February 2021 (Four years 13 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹1.08 Cr.
Rajendra Garg and Rathnamani Arkachari serve as directors at the Company.
Company Details
- Location
Jaipur, Rajasthan, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U85300RJ2021PTC073469
- Company No.
073469
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Feb 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Kedar Diagnostics And Healthcare?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajendra Garg  | Director | 12-Feb-2021 | Current |
| Rathnamani Arkachari | Director | 21-Mar-2024 | Current |
Financial Performance of Kedar Diagnostics And Healthcare.
Enhance accessibility to Kedar Diagnostics And Healthcare's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Kedar Diagnostics And Healthcare?
Unlock access to Kedar Diagnostics And Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
₹10.77 M
₹0
Charges Breakdown by Lending Institutions
- Others : 0.92 Cr
- Hdfc Bank Limited : 0.16 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jul 2024 | Others | ₹2.98 M | Open |
| 16 Jan 2024 | Others | ₹4.40 M | Open |
| 28 Jun 2023 | Others | ₹1.79 M | Open |
| 28 Nov 2022 | Hdfc Bank Limited | ₹1.61 M | Open |
How Many Employees Work at Kedar Diagnostics And Healthcare?
Kedar Diagnostics And Healthcare has a workforce of 0 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kedar Diagnostics And Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kedar Diagnostics And Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
